Skip to Content

Join the 'Benlysta' group to help and get support from people like you.

Benlysta News

GSK Receives FDA Approval for a New Self-Injectable Formulation of Benlysta (belimumab) for Systemic Lupus Erythematosus

Posted 24 Jul 2017 by Drugs.com

London, UK 21 July 2017 – GSK announced today that the US Food and Drug Administration (FDA) has approved a new subcutaneous formulation of Benlysta (belimumab) for the treatment of adult patients with active, autoantibody‑positive SLE who are receiving standard therapy. Systemic Lupus Erythematosus (SLE) is the most common form of lupus, a chronic, incurable autoimmune disease producing autoantibodies that can attack almost any system in the body. The approval marks the first subcutaneous self-injection treatment option for patients with SLE. After training from their health care provider, patients will be able to administer the medicine as a once weekly injection of 200mg, from either a single-dose prefilled syringe or from a single-dose autoinjector. This is the second formulation of Benlysta to be granted approval for SLE, adding to the existing intravenous (IV) formulation, a ... Read more

Related support groups: Systemic Lupus Erythematosus, Lupus Erythematosus, Benlysta, Belimumab

Kidney Woes Tied to Raised Cancer Risk, Study Finds

Posted 12 Nov 2015 by Drugs.com

THURSDAY, Nov. 12, 2015 – Kidney failure and having a kidney transplant may increase the risk for certain types of cancer, a new study suggests. Poor kidney function and immune system-suppressing drugs may be behind this increased risk, according to Elizabeth Yanik, of the U.S. National Cancer Institute, and colleagues. For the study, published in the Nov. 12 online edition of the Journal of the American Society of Nephrology, the researchers looked at data from more than 200,000 U.S. kidney transplant candidates and recipients. Along with finding that these patients are at increased risk for certain types of cancer, the investigators also identified clear patterns of risk associated with different types of treatment. However, the associations seen in the study do not prove cause-and-effect. The risk of kidney and thyroid cancers was especially high when kidney failure patients were on ... Read more

Related support groups: Cancer, Methotrexate, Renal Failure, CellCept, Gilenya, Tysabri, Imuran, Xolair, Orencia, Chronic Kidney Disease, Revlimid, Leflunomide, Arava, Azathioprine, Afinitor, Tecfidera, Mycophenolate Mofetil, Peritoneal dialysis, Entyvio, Aubagio

Strides Made in Diagnosing, Treating Lupus

Posted 10 May 2012 by Drugs.com

THURSDAY, May 10 – Sometimes it takes years for people to get diagnosed with lupus. That wasn't the case for Marisa Zeppieri-Caruana, who had so many of the classic systemic lupus erythematosus symptoms – such as a butterfly-shaped rash on her face, a daily fever and achy joints – that her doctor knew right away that the 23-year-old had the illness. Since then, Zeppieri-Caruana, now 34, has been hospitalized 30 times and has had four mini-strokes along with numerous other problems related to her lupus. Most people who have lupus go through periods where they have active disease (flares) and periods where they don't have any symptoms (remission). Unfortunately, Zeppieri-Caruana said she's never had a time where she's been totally in remission. "An average day for me includes fatigue and fever. It's really hard to try to put weight on, and I usually don't feel like doing anything. I ... Read more

Related support groups: Prednisone, Aspirin, Systemic Lupus Erythematosus, Methylprednisolone, Prednisolone, Plaquenil, Hydrocortisone, Medrol, Dexamethasone, Cortisone, Triamcinolone, Hydroxychloroquine, Betamethasone, Budesonide, Decadron, Entocort, Lupus Erythematosus, Solu-Medrol, Entocort EC, Ecotrin

Ask a Question

Further Information

Related Condition Support Groups

Systemic Lupus Erythematosus

Benlysta Patient Information at Drugs.com